Inflammatory Bowel Diseases · Published 2026-07-07 · DOI 10.1093/ibd/izag143
Sama Anvari, Wasuwit Wanchaitanawong, Xin Xiong, Tianxi Cai, Ashwin N Ananthakrishnan
PubPorta does not have an abstract for this article yet.
Read the article at the publisher →
Anvari, S., Wanchaitanawong, W., Xiong, X., et al. (2026). Cancer risk with methotrexate-TNF antagonist combination therapy compared to TNF-antagonist monotherapy in IBD. Inflammatory Bowel Diseases. https://doi.org/10.1093/ibd/izag143